Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 9Stomach Neoplasms 1Pancreatic Neoplasms 1Nephrotic Syndrome 1Neoplasm Metastasis 1Kidney Diseases 1Hepatitis B 1Gastrointestinal Diseases 1Familial Mediterranean Fever 1Esophageal Neoplasms 1Colorectal Adenocarcinoma 1Cholangiocarcinoma 1BRAF V600 Colorectal Cancer 1Arthritis, Rheumatoid 1Amyloidosis 1Adenomatous Polyposis Coli 1

Interventions

entecavir 4lenvatinib 2Tenofovir 2Sorafenib 2Radiofrequency Ablation 2Lamivudine 2polysaccharide MGN3 1peginterferon alfa-2b 1peginterferon alfa-2a 1navitoclax 1menatetrenone 1lens intermediate filament proteins 1hepatitis B hyperimmune globulin 1adefovir dipivoxil 1adefovir 1Urinalysis 1Ultrasonography 1Tumor Necrosis Factor-alpha 1Telbivudine 1Rapid Diagnostic Tests 1Raltegravir Potassium 1Radiomics 1Polymorphism, Genetic 1Pharmaceutical Preparations 1PHY 906 1Nucleosides 1Nivolumab 1Interferons 1Hypothermia, Induced 1Hepatitis B Vaccines 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hepatitis B × Pharmaceutical Preparations × Gastrointestinal × Clear all
NCT05406089 2022-06-21

Effects of Antiviral Therapy on Patients With HBV-related HCC

First Affiliated Hospital Xi'an Jiaotong University

Completed
494 enrolled
Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡